Investigative site

Miami, Florida 33186

0 studies enrolling now · 23 studies all time

What they study most

Alport Syndrome, Cardiovascular Diseases, Chronic Idiopathic Constipation, Constipation, Covid19, Focal Segmental Glomerulosclerosis, HIV I Infection, Healthy, Heavy Menstrual Bleeding, Hepatitis B, Chronic, Hepatitis C, Hypertension

Studies at this site

• Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus — Completed
• Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection — Completed
• Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2) — Running, not enrolling
• A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease — Stopped early
• Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis — Completed
• Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease — Completed
• A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A — Stopped early
• Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19. — Stopped early
• Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19 — Completed
• VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers — Completed
• VIR-7831 for the Early Treatment of COVID-19 in Outpatients — Completed
• Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes — Completed
• Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo — Completed
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — Completed
• Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects — Completed
• Efficacy and Safety of XP12B in Women With Menorrhagia — Completed
• Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia — Completed
• Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects — Completed
• Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. — Stopped early
• Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain — Stopped early
• Efficacy and Safety Study of XP12B in Women With Menorrhagia — Completed
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension. — Completed
• Safety Study of XP12B in Women With Menorrhagia — Completed